# Multimodal single-cell profiling reveals crosstalk between macrophages and stromal cells in poor prognostic cholangiocarcinoma patients

**Authors:** Lara Heij, Sikander Hayat, Konrad Reichel, Sidrah Maryam, Colm J. O’Rourke, Xiuxiang Tan, Marlous van den Braber, Jan Verhoeff, Maurice Halder, Fabian Peisker, Georg Wiltberger, Jan Bednarsch, Daniel Heise, Julia Campello Deierl, Sven A. Lang, Florian Ulmer, Tom Luedde, Edgar Dahl, Danny Jonigk, Jochen Nolting, Shivan Sivakumar, Jens Siveke, Florian Vondran, Flavio G. Rocha, Hideo A. Baba, Sylvia Hartmann, Jesper B. Andersen, Zaynab Hobloss, Ahmed Ghallab, Jan G. Hengstler, Juan J. Garcia Vallejo, Rafael Kramann, Ulf Neumann

PMC · DOI: 10.1038/s41698-026-01292-6 · 2026-01-28

## TL;DR

This study explores how immune cells interact in the tumor environment of cholangiocarcinoma, revealing communication between stromal cells and macrophages that worsen patient outcomes.

## Contribution

The study identifies specific receptor-ligand pairs involved in immune suppression in cholangiocarcinoma.

## Key findings

- Tumor-infiltrating T cells show signs of exhaustion in cholangiocarcinoma.
- Cellular crosstalk in poor prognosis patients is driven by stromal cells and macrophages.
- Key receptor-ligand pairs include GAS6-AXL, VCAN-TLR2, and EGFR-TGF-β.

## Abstract

Cholangiocarcinoma (CCA) is a deadly cancer, characterized by abundant stroma. The tumor microenvironment (TME) plays an important role in its aggressive behavior and poor response to therapeutics; however, the underlying pathways are unknown. To fill this gap, we used multiplexed immunohistochemistry, high-dimensional cytometry, and single cell transcriptomics. Our findings confirm an abundance of regulatory T cells (Tregs) and a lack of effector memory T cells within the tumor. Tumor-infiltrating T cells show signs of exhaustion. Using our transcriptomic data, we revealed cellular crosstalk in poor prognosis patients. This crosstalk is driven by stromal cells and macrophages. Among the responsible receptor-ligand pairs are GAS6-AXL, VCAN-TLR2, and EGFR-TGF-β. The multiple mechanisms leading to the exclusion of relevant immune cells needed for an anti-cancer response and mechanisms leading to active immune suppression are part of complex cell-cell crosstalk. This study provides a deeper insight into the immune exhausted phenotype in CCA.

## Linked entities

- **Proteins:** GAS6 (growth arrest specific 6), AXL (AXL receptor tyrosine kinase), VCAN (versican), TLR2 (toll like receptor 2), EGFR (epidermal growth factor receptor), TGFB1 (transforming growth factor beta 1)
- **Diseases:** cholangiocarcinoma (MONDO:0019087)

## Full-text entities

- **Genes:** EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, AXL (AXL receptor tyrosine kinase) [NCBI Gene 558] {aka ARK, AXL3, JTK11, Tyro7, UFO}, VCAN (versican) [NCBI Gene 1462] {aka CSPG2, ERVR, GHAP, PG-M, WGN, WGN1}, GAS6 (growth arrest specific 6) [NCBI Gene 2621] {aka AXLLG, AXSF}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, TLR2 (toll like receptor 2) [NCBI Gene 7097] {aka CD282, TIL4}
- **Diseases:** CCA (MESH:D018281), Tumor (MESH:D009369)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12976350/full.md

---
Source: https://tomesphere.com/paper/PMC12976350